Genomic risk factors in sudden infant death syndrome

Genome Medicine

Volumn 2, Issue 11, 2010, Pages

  Van Norstrand, David W ^a   Ackerman, Michael J ^a,b  

^a MAYO GRADUATE SCHOOL   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 1A1; GLUCOSE 6 PHOSPHATE; GLUTATHIONE TRANSFERASE T1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; NICOTINE; SEROTONIN; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

AUTOIMMUNE DISEASE; AUTONOMIC NERVOUS SYSTEM; BASE PAIRING; CARDIAC CHANNELOPATHY; CENTRAL NERVOUS SYSTEM; COPY NUMBER VARIATION; ENERGY; ETHNICITY; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC CODE; GENETIC RISK; GENETIC VARIABILITY; HEREDITY; HUMAN; INBORN ERROR OF METABOLISM; INFANT; POPULATION; POSTNATAL CARE; PRENATAL CARE; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; RISK ASSESSMENT; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SUDDEN INFANT DEATH SYNDROME;

EID: 78751684508     PISSN: None     EISSN: 1756994X     Source Type: Journal    
DOI: 10.1186/gm207     Document Type: Review

References (102)

1. Kinney HC, Thach BT. The sudden infant death syndrome. N Engl J Med 2009, 361:795-805. 10.1056/NEJMra0803836, 19692691.
2. Willinger M, James LS, Catz C. Defining the sudden infant death syndrome (SIDS): deliberations of an expert panel convened by the National Institute of Child Health and Human Development. Pediatr Pathol 1991, 11:677-684. 10.3109/15513819109065465, 1745639.
3. Guntheroth WG, Spiers PS. The triple risk hypotheses in sudden infant death syndrome. Pediatrics 2002, 110:e64. 10.1542/peds.110.5.e64, 12415070.
4. Hunt CE, Hauck FR. Sudden infant death syndrome. CMAJ 2006, 174:1861-1869. 1475900, 16785462.
5. Mathews TJ, MacDorman MF. Infant mortality statistics from the 2004 period linked birth/infant death data set. Natl Vital Stat Rep 2007, 55:1-32.
6. Moon RY, Horne RS, Hauck FR. Sudden infant death syndrome. Lancet 2007, 370:1578-1587. 10.1016/S0140-6736(07)61662-6, 17980736.
7. Arnestad M, Vege A, Rognum TO. Evaluation of diagnostic tools applied in the examination of sudden unexpected deaths in infancy and early childhood. Forensic Sci Int 2002, 125:262-268. 10.1016/S0379-0738(02)00009-9, 11909674.
8. Cote A, Russo P, Michaud J. Sudden unexpected deaths in infancy: what are the causes?. J Pediatr 1999, 135:437-443. 10.1016/S0022-3476(99)70165-4, 10518077.
9. Molteno CD, Ress E, Kibel MA. Early childhood mortality in Cape Town. S Afr Med J 1989, 75:570-574.
10. Weinberg SB, Purdy BA. Postmortem leukocyte culture studies in sudden infant death. Nature 1970, 226:1264-1265. 10.1038/2261264a0, 5463603.
11. Vege T, Rognum T. Use of new Nordic criteria for classification of SIDS to re-evaluate diagnoses of sudden unexpected infant death in the Nordic countries. Acta Paediatr 1997, 86:391-396. 10.1111/j.1651-2227.1997.tb09029.x, 9174226.
12. Krous HF, Beckwith JB, Byard RW, Rognum TO, Bajanowski T, Corey T, Cutz E, Hanzlick R, Keens TG, Mitchell EA. Sudden infant death syndrome and unclassified sudden infant deaths: a definitional and diagnostic approach. Pediatrics 2004, 114:234-238. 10.1542/peds.114.1.234, 15231934.
13. Kinney HC, Richerson GB, Dymecki SM, Darnall RA, Nattie EE. The brainstem and serotonin in the sudden infant death syndrome. Annu Rev Pathol 2009, 4:517-550. 10.1146/annurev.pathol.4.110807.092322, 19400695.
14. Weese-Mayer DE, Ackerman MJ, Marazita ML, Berry-Kravis EM. Sudden infant death syndrome: review of implicated genetic factors. Am J Med Genet A 2007, 143A:771-788.
15. Narita N, Narita M, Takashima S, Nakayama M, Nagai T, Okado N. Serotonin transporter gene variation is a risk factor for sudden infant death syndrome in the Japanese population. Pediatrics 2001, 107:690-692. 10.1542/peds.107.4.690, 11335745.
16. Heils A, Teufel A, Petri S, Stober G, Riederer P, Bengel D, Lesch KP. Allelic variation of human serotonin transporter gene expression. J Neurochem 1996, 66:2621-2624. 10.1046/j.1471-4159.1996.66062621.x, 8632190.
17. Paterson DS, Trachtenberg FL, Thompson EG, Belliveau RA, Beggs AH, Darnall R, Chadwick AE, Krous HF, Kinney HC. Multiple serotonergic brainstem abnormalities in sudden infant death syndrome. JAMA 2006, 296:2124-2132. 10.1001/jama.296.17.2124, 17077377.
18. Ozawa Y, Okado N. Alteration of serotonergic receptors in the brain stems of human patients with respiratory disorders. Neuropediatrics 2002, 33:142-149. 10.1055/s-2002-33678, 12200744.
19. Panigrahy A, Filiano J, Sleeper LA, Mandell F, Valdes-Dapena M, Krous HF, Rava LA, Foley E, White WF, Kinney HC. Decreased serotonergic receptor binding in rhombic lip-derived regions of the medulla oblongata in the sudden infant death syndrome. J Neuropathol Exp Neurol 2000, 59:377-384.
20. Hunt CE, Hauck FR. Sudden infant death syndrome. Nelson Textbook of Pediatrics 2007, 1736-1741. Philadelphia: Saunders, Kliegmann RM, 18.
21. Lavezzi AM, Casale V, Oneda R, Weese-Mayer DE, Matturri L. Sudden infant death syndrome and sudden intrauterine unexplained death: correlation between hypoplasia of raphe nuclei and serotonin transporter gene promoter polymorphism. Pediatr Res 2009, 66:22-27. 10.1203/PDR.0b013e3181a7bb73, 19342987.
22. Nonnis Marzano F, Maldini M, Filonzi L, Lavezzi AM, Parmigiani S, Magnani C, Bevilacqua G, Matturri L. Genes regulating the serotonin metabolic pathway in the brain stem and their role in the etiopathogenesis of the sudden infant death syndrome. Genomics 2008, 91:485-491. 10.1016/j.ygeno.2008.01.010, 18387780.
23. Weese-Mayer DE, Berry-Kravis EM, Maher BS, Silvestri JM, Curran ME, Marazita ML. Sudden infant death syndrome: association with a promoter polymorphism of the serotonin transporter gene. Am J Med Genet A 2003, 117A:268-274. 10.1002/ajmg.a.20005, 12599191.
24. Haas C, Braun J, Bär W, Bartsch C. No association of serotonin transporter gene variation with sudden infant death syndrome (SIDS) in Caucasians. Leg Med (Tokyo) 2009, 11:S210-S212.
25. Opdal SH, Vege T, Rognum TO. Serotonin transporter gene variation in sudden infant death syndrome. Acta Paediatr 2008, 97:861-865. 10.1111/j.1651-2227.2008.00813.x, 18477062.
26. Fiskerstrand CE, Lovejoy EA, Quinn JP. An intronic polymorphic domain often associated with susceptibility to affective disorders has allele dependent differential enhancer activity in embryonic stem cells. FEBS Lett 1999, 458:171-174. 10.1016/S0014-5793(99)01150-3, 10481059.
27. Weese-Mayer DE, Zhou L, Berry-Kravis EM, Maher BS, Silvestri JM, Marazita ML. Association of the serotonin transporter gene with sudden infant death syndrome: a haplotype analysis. Am J Med Genet A 2003, 122A:238-245. 10.1002/ajmg.a.20427, 12966525.
28. Filonzi L, Magnani C, Lavezzi A, Rindi G, Parmigiani S, Bevilacqua G, Matturri L, Nonnis Marzano F. Association of dopamine transporter and monoamine oxidase molecular polymorphisms with sudden infant death syndrome and stillbirth: new insights into the serotonin hypothesis. Neurogenetics 2009, 10:65-72. 10.1007/s10048-008-0149-x, 18810510.
29. Morley ME, Rand CM, Berry-Kravis EM, Zhou L, Fan W, Weese-Mayer DE. Genetic variation in the HTR1A gene and sudden infant death syndrome. Am J Med Genet A 2008, 146:930-933. 10.1002/ajmg.a.32112, 18286597.
30. Rand CM, Berry-Kravis EM, Fan W, Weese-Mayer DE. HTR2A variation and sudden infant death syndrome: a case-control analysis. Acta Paediatr 2009, 98:58-61. 10.1111/j.1651-2227.2008.01018.x, 18771483.
31. Rand CM, Berry-Kravis EM, Zhou L, Fan W, Weese-Mayer DE. Sudden infant death syndrome: rare mutation in the serotonin system FEV gene. Pediatr Res 2007, 62:180-182. 10.1203/PDR.0b013e3180a725a0, 17597646.
32. Broadbelt KG, Barger MA, Paterson DS, Holm IA, Haas EA, Krous HF, Kinney HC, Markianos K, Beggs AH. Serotonin-related FEV gene variant in the sudden infant death syndrome is a common polymorphism in the African-American population. Pediatr Res 2009, 66:631-635. 10.1203/PDR.0b013e3181bd5a31, 19707175.
33. Weese-Mayer DE, Berry-Kravis EM, Zhou L, Maher BS, Curran ME, Silvestri JM, Marazita ML. Sudden infant death syndrome: case-control frequency differences at genes pertinent to early autonomic nervous system embryologic development. Pediatr Res 2004, 56:391-395. 10.1203/01.PDR.0000136285.91048.4A, 15240857.
34. Rand CM, Weese-Mayer DE, Zhou L, Maher BS, Cooper ME, Marazita ML, Berry-Kravis EM. Sudden infant death syndrome: Case-control frequency differences in paired like homeobox (PHOX) 2B gene. Am J Med Genet A 2006, 140:1687-1691.
35. Kijima K, Sasaki A, Niki T, Umetsu K, Osawa M, Matoba R, Hayasaka K. Sudden infant death syndrome is not associated with the mutation of PHOX2B gene, a major causative gene of congenital central hypoventilation syndrome. Tohoku J Exp Med 2004, 203:65-68. 10.1620/tjem.203.65, 15185974.
36. Weese-Mayer DE, Berry-Kravis EM, Ceccherini I, Rand CM. Congenital central hypoventilation syndrome (CCHS) and sudden infant death syndrome (SIDS): kindred disorders of autonomic regulation. Respir Physiol Neurobiol 2008, 164:38-48. 10.1016/j.resp.2008.05.011, 18579454.
37. Becher J-C, Keeling JW, Bell J, Wyatt B, McIntosh N. Apolipoprotein E e4 and its prevalence in early childhood death due to sudden infant death syndrome or to recognised causes. Early Hum Dev 2008, 84:549-554. 10.1016/j.earlhumdev.2008.01.002, 18280677.
38. Cummings KJ, Klotz C, Liu WQ, Weese-Mayer DE, Marazita ML, Cooper ME, Berry-Kravis EM, Tobias R, Goldie C, Bech-Hansen NT, Wilson RJ. Sudden infant death syndrome (SIDS) in African Americans: polymorphisms in the gene encoding the stress peptide pituitary adenylate cyclase-activating polypeptide (PACAP). Acta Paediatr 2009, 98:482-489. 10.1111/j.1651-2227.2008.01131.x, 19120039.
39. Klintschar M, Reichenpfader B, Saternus K-S. A functional polymorphism in the tyrosine hydroxylase gene indicates a role of noradrenalinergic signaling in sudden infant death syndrome. J Pediatr 2008, 153:190-193. 10.1016/j.jpeds.2008.02.032, 18534229.
40. Van Norstrand DW, Ackerman MJ. Sudden infant death syndrome: do ion channels play a role?. Heart Rhythm 2009, 6:272-278. 10.1016/j.hrthm.2008.07.028, 18823823.
41. Schwartz PJ. Cardiac sympathetic innervation and the sudden infant death syndrome: a possible pathogenic link. Am J Med 1976, 60:167-172. 10.1016/0002-9343(76)90425-3, 175654.
42. Maron BJ, Clark CE, Goldstein RE, Epstein SE. Potential role of QT interval prolongation in sudden infant death syndrome. Circulation 1976, 54:423-430.
43. Schwartz PJ, Crotti L. Ion channel diseases in children: manifestations and management. Curr Opin Cardiol 2008, 23:184-191. 10.1097/HCO.0b013e3282fcc2e3, 18382205.
44. Ackerman MJ. The long QT syndrome: ion channel diseases of the heart. Mayo Clin Proc 1998, 73:250-269. 10.4065/73.3.250, 9511785.
45. Schwartz PJ, Stramba-Badiale M, Segantini A, Austoni P, Bosi G, Giorgetti R, Grancini F, Marni ED, Perticone F, Rosti D, Salice P. Prolongation of the QT interval and the sudden infant death syndrome. N Engl J Med 1998, 338:1709-1714. 10.1056/NEJM199806113382401, 9624190.
46. Schwartz PJ, Priori SG, Dumaine R, Napolitano C, Antzelevitch C, Stramba-Badiale M, Richard TA, Berti MR, Bloise R. A molecular link between the sudden infant death syndrome and the long-QT syndrome. N Engl J Med 2000, 343:262-267. 10.1056/NEJM200007273430405, 10911008.
47. Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol 1992, 20:1391-1396. 10.1016/0735-1097(92)90253-J, 1309182.
48. Tester DJ, Kopplin LJ, Will ML, Ackerman MJ. Spectrum and prevalence of cardiac ryanodine receptor (RyR2) mutations in a cohort of unrelated patients referred explicitly for long QT syndrome genetic testing. Heart Rhythm 2005, 2:1099-1105. 10.1016/j.hrthm.2005.07.012, 16188589.
49. Allouis M, Probst V, Jaafar P, Schott JJ, Le Marec H. Unusual clinical presentation in a family with catecholaminergic polymorphic ventricular tachycardia due to a G14876A ryanodine receptor gene mutation. Am J Cardiol 2005, 95:700-702. 10.1016/j.amjcard.2004.10.057, 15721128.
50. Ackerman MJ, Siu BL, Sturner WQ, Tester DJ, Valdivia CR, Makielski JC, Towbin JA. Postmortem molecular analysis of SCN5A defects in sudden infant death syndrome. JAMA 2001, 286:2264-2269. 10.1001/jama.286.18.2264, 11710892.
51. Tester DJ, Ackerman MJ. Sudden infant death syndrome: how significant are the cardiac channelopathies?. Cardiovasc Res 2005, 67:388-396. 10.1016/j.cardiores.2005.02.013, 15913580.
52. Arnestad M, Crotti L, Rognum TO, Insolia R, Pedrazzini M, Ferrandi C, Vege A, Wang DW, Rhodes TE, George AL, Schwartz PJ. Prevalence of long-QT syndrome gene variants in sudden infant death syndrome. Circulation 2007, 115:361-367. 10.1161/CIRCULATIONAHA.106.658021, 17210839.
53. Wang DW, Desai RR, Crotti L, Arnestad M, Insolia R, Pedrazzini M, Ferrandi C, Vege A, Rognum T, Schwartz PJ, George AL. Cardiac sodium channel dysfunction in sudden infant death syndrome. Circulation 2007, 115:368-376. 10.1161/CIRCULATIONAHA.106.646513, 17210841.
54. Rhodes TE, Abraham RL, Welch RC, Vanoye CG, Crotti L, Arnestad M, Insolia R, Pedrazzini M, Ferrandi C, Vege A, Rognum T, Roden DM, Schwartz PJ, Goerge AL. Cardiac potassium channel dysfunction in sudden infant death syndrome. J Mol Cell Cardiol 2008, 44:571-581. 10.1016/j.yjmcc.2007.11.015, 2386856, 18222468.
55. Cheng J, Van Norstrand DW, Medeiros-Domingo A, Valdivia C, Tan BH, Ye B, Kroboth S, Vatta M, Tester DJ, January CT, Makielski JC, Ackerman MJ. α1-Syntrophin mutations identified in sudden infant death syndrome cause an increase in late cardiac sodium current. Circ Arrhythm Electrophysiol 2009, 2:667-676. 10.1161/CIRCEP.109.891440, 20009079.
56. Cronk LB, Ye B, Kaku T, Tester DJ, Vatta M, Makielski JC, Ackerman MJ. Novel mechanism for sudden infant death syndrome: persistent late sodium current secondary to mutations in caveolin-3. Heart Rhythm 2007, 4:161-166. 10.1016/j.hrthm.2006.11.030, 2836535, 17275750.
57. Tan B-H, Pundi KN, Van Norstrand DW, Valdivia CR, Tester DJ, Medeiros-Domingo A, Makielski JC, Ackerman MJ. Sudden infant death syndrome-associated mutations in the sodium channel beta subunits. Heart Rhythm 2010, 7:771-778. 10.1016/j.hrthm.2010.01.032, 20226894.
58. Van Norstrand DW, Valdivia CR, Tester DJ, Ueda K, London B, Makielski JC, Ackerman MJ. Molecular and functional characterization of novel glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-L) mutations in sudden infant death syndrome. Circulation 2007, 116:2253-2259. 10.1161/CIRCULATIONAHA.107.704627, 17967976.
59. Osawa M, Kimura R, Hasegawa I, Mukasa N, Satoh F. SNP association and sequence analysis of the NOS1AP gene in SIDS. Leg Med (Tokyo) 2009, 11:S307-S308.
60. Aarnoudse AJ, Newton-Cheh C, de Bakker PI, Straus SM, Kors JA, Hofman A, Uitterlinden AG, Witteman JC, Stricker BH. Common NOS1AP variants are associated with a prolonged QTc interval in the Rotterdam Study. Circulation 2007, 116:10-16. 10.1161/CIRCULATIONAHA.106.676783, 17576865.
61. Lehtinen AB, Newton-Cheh C, Ziegler JT, Langefeld CD, Freedman BI, Daniel KR, Herrington DM, Bowden DW. Association of NOS1AP genetic variants with QT interval duration in families from the Diabetes Heart Study. Diabetes 2008, 57:1108-1114. 10.2337/db07-1365, 18235038.
62. Arnestad M, Opdal SH, Vege A, Rognum TO. A mitochondrial DNA polymorphism associated with cardiac arrhythmia investigated in sudden infant death syndrome. Acta Paediatr 2007, 96:206-210. 10.1111/j.1651-2227.2007.00022.x, 17429906.
63. Plant LD, Bowers PN, Liu QY, Morgan T, Zhang TT, State MW, Chen WD, Kittles RA, Goldstein SAN. A common cardiac sodium channel variant associated with sudden infant death in African Americans, SCN5A S1103Y. J Clin Invest 2006, 116:430-435. 10.1172/JCI25618, 1359045, 16453024.
64. Van Norstrand DW, Tester DJ, Ackerman MJ. Overrepresentation of the proarrhythmic, sudden death predisposing sodium channel polymorphism S1103Y in a population-based cohort of African-American sudden infant death syndrome. Heart Rhythm 2008, 5:712-715. 10.1016/j.hrthm.2008.02.012, 2430043, 18452875.
65. Schwartz PJ. The congenital long QT syndromes from genotype to phenotype: clinical implications. J Intern Med 2006, 259:39-47. 10.1111/j.1365-2796.2005.01583.x, 16336512.
66. Tester DJ, Ackerman MJ. Postmortem long QT syndrome genetic testing for sudden unexplained death in the young. J Am Coll Cardiol 2007, 49:240-246. 10.1016/j.jacc.2006.10.010, 17222736.
67. Vatta M, Dumaine R, Varghese G, Roichard TA, Shimizu W, Aihara N, Nademanee K, Brugada R, Brugada J, Veerakul G, Li H, Bowles NE, Brugada P, Antzelevitch C, Towbin JA. Genetic and biophysical basis of sudden unexplained nocturnal death syndrome (SUNDS), a disease allelic to Brugada syndrome. Hum Mol Genet 2002, 11:337-345. 10.1093/hmg/11.3.337, 11823453.
68. Blackwell C, Moscovis SM, Gordon AE, Al Madani OM, Hall ST, Gleeson M, Scott RJ, Roberts-Thomson J, Weir DM, Busuttil A. Ethnicity, infection and sudden infant death syndrome. FEMS Immunol Med Microbiol 2004, 42:53-65. 10.1016/j.femsim.2004.06.007, 15325398.
69. Blackwell CC, Moscovis SM, Gordon AE, Al Madani OM, Hall ST, Gleeson M, Scott RJ, Roberts-Thomson J, Weir DM, Busuttil A. Cytokine responses and sudden infant death syndrome: genetic, developmental, and environmental risk factors. J Leukoc Biol 2005, 78:1242-1254. 10.1189/jlb.0505253, 16204631.
70. Summers AM, Summers CW, Drucker DB, Hajeer AH, Barson A, Hutchinson IV. Association of IL-10 genotype with sudden infant death syndrome. Hum Immunol 2000, 61:1270-1273. 10.1016/S0198-8859(00)00183-X, 11163082.
71. Opdal SH, Opstad A, Vege T, Rognum TO. Il-10 gene polymorphisms are associated with infectious cause of sudden infant death. Hum Immunol 2003, 64:1183-1189. 10.1016/j.humimm.2003.08.359, 14630401.
72. Moscovis SM, Gordon AE, Al Madani OM, Gleeson M, Scott RJ, Roberts-Thomson J, Hall ST, Weir DM, Busuttil A, Blackwell C. Interleukin-10 and sudden infant death syndrome. FEMS Immunol Med Microbiol 2004, 42:130-138. 10.1016/j.femsim.2004.06.020, 15325406.
73. Korachi M, Pravica V, Barson AJ, Hutchinson IV, Drucker D. Interleukin 10 genotype as a risk factor for sudden infant death syndrome: determination of IL-10 genotype from wax-embedded postmortem samples. FEMS Immunol Med Microbiol 2004, 42:125-129. 10.1016/j.femsim.2004.06.008, 15325405.
74. Perskvist N, Skoglund K, Edston E, Backstrom G, Lodestad I, Palm U. TNF-α and IL-10 gene polymorphisms versus cardioimmunological responses in sudden infant death. Fetal Pediatr Pathol 2008, 27:149-165. 10.1080/15513810802077651, 18633768.
75. Dashash M, Pravica V, Hutchinson IV, Barson AJ, Drucker DB. Association of sudden infant death syndrome with VEGF and IL-6 gene polymorphisms. Hum Immunol 2006, 67:627-633. 10.1016/j.humimm.2006.05.002, 16916659.
76. Ferrante L, Opdal S, Vege T, Rognum T. Cytokine gene polymorphisms and sudden infant death syndrome. Acta Paediatr 2010, 99:384-388. 10.1111/j.1651-2227.2009.01611.x, 19958302.
77. Moscovis SM, Gordon AE, Al Madani OM, Gleeson M, Scott RJ, Roberts-Thomson J, Hall ST, Weir DM, Busuttil A, Blackwell CC. IL6 G-174C associated with sudden infant death syndrome in a Caucasian Australian cohort. Hum Immunol 2006, 67:819-825. 10.1016/j.humimm.2006.07.010, 17055359.
78. Opdal SH, Rognum TO. The IL6 -174G/C polymorphism and sudden infant death syndrome. Hum Immunol 2007, 68:541-543. 10.1016/j.humimm.2007.02.008, 17509454.
79. Ferrante L, Opdal SH, Vege T, Rognum TO. IL-1 gene cluster polymorphisms and sudden infant death syndrome. Hum Immunol 2010, 71:402-406. 10.1016/j.humimm.2010.01.011, 20080142.
80. Ferrante L, Opdal SH, Vege T, Rognum TO. TNF-α promoter polymorphisms in sudden infant death. Hum Immunol 2008, 69:368-373. 10.1016/j.humimm.2008.04.006, 18571009.
81. Highet AR, Berry AM, Goldwater PN. Distribution of interleukin-1 receptor antagonist genotypes in Sudden Unexpected Death in Infancy (SUDI); unexplained SUDI have a higher frequency of allele 2. Ann Med 2010, 42:64-69. 10.3109/07853890903325360, 20092400.
82. Opdal SH, Vege A, Saugstad OD, Rognum TO. Is partial deletion of the complement C4 genes associated with sudden infant death?. Eur J Pediatr 1994, 153:287-290. 10.1007/BF01954522, 8194566.
83. Opdal SH, Vege T, Stave AK, Rognum TO. The complement component C4 in sudden infant death. Eur J Pediatr 1999, 158:210-212. 10.1007/s004310051051, 10094440.
84. Moczulski D, Majak I, Mamczur D. An overview of β-oxidation disorders. Postepy Hig Med Dosw (Online) 2009, 63:266-277.
85. Lundemose JB, Kolvraa S, Gregersen N, Christensen E, Gregersen M. Fatty acid oxidation disorders as primary cause of sudden and unexpected death in infants and young children: an investigation performed on cultured fibroblasts from 79 children who died aged between 0-4 years. Mol Pathol 1997, 50:212-217. 10.1136/mp.50.4.212, 379629, 9350306.
86. Yang Z, Lantz PE, Ibdah JA. Post-mortem analysis for two prevalent β-oxidation mutations in sudden infant death. Pediatr Int 2007, 49:883-887. 10.1111/j.1442-200X.2007.02478.x, 18045290.
87. Aarskog NK, Ogreid D. Aldolase B A149P mutation and hereditary fructose intolerance are not associated with sudden infant death syndrome. Acta Paediatr 1995, 84:947-948. 10.1111/j.1651-2227.1995.tb13801.x, 7488826.
88. Forsyth L, Hume R, Howatson A, Busuttil A, Burchell A. Identification of novel polymorphisms in the glucokinase and glucose-6-phosphatase genes in infants who died suddenly and unexpectedly. J Mol Med 2005, 83:610-618. 10.1007/s00109-005-0666-0, 15918042.
89. Forsyth L, Scott H, Howatson A, Busuttil A, Hume R, Burchell A. Genetic variation in hepatic glucose-6-phosphatase system genes in cases of sudden infant death syndrome. J Pathol 2007, 212:112-120. 10.1002/path.2147, 17354259.
90. Hofmann S, Jaksch M, Bezold R, Mertens S, Aholt S, Paprotta A, Gerbitz KD. Population genetics and disease susceptibility: characterization of central European haplogroups by mtDNA gene mutations, correlation with D loop variants and association with disease. Hum Mol Genet 1997, 6:1835-1846. 10.1093/hmg/6.11.1835, 9302261.
91. Opdal S, Rognum T, Torgersen H, Vege T. Mitochondrial DNA point mutations detected in four cases of sudden infant death syndrome. Acta Paediatr 1999, 88:957-960. 10.1080/08035259950168441, 10519336.
92. Adgent MA. Environmental tobacco smoke and sudden infant death syndrome: a review. Birth Defects Res B Dev Reprod Toxicol 2006, 77:69-85. 10.1002/bdrb.20068, 16496293.
93. Rand CM, Weese-Mayer DE, Maher BS, Zhou L, Marazita ML, Berry-Kravis EM. Nicotine metabolizing genes GSTT1 and CYP1A1 in sudden infant death syndrome. Am J Med Genet A 2006, 140A:1447-1452.
94. Poetsch M, Czerwinski M, Wingenfeld L, Vennemann M, Bajanowski T. A common FMO3 polymorphism may amplify the effect of nicotine exposure in sudden infant death syndrome (SIDS). Int J Legal Med 2010, 124:301-306. 10.1007/s00414-010-0428-6, 20198379.
95. Sutherland GR, Carter RF. Cytogenetic studies: an essential part of the paediatric necropsy. J Clin Pathol 1983, 36:140-142. 10.1136/jcp.36.2.140, 498140, 6681820.
96. Toruner G, Kurvathi R, Sugalski R, Shulman L, Twersky S, Pearson P, Tozzi R, Schwalb M, Wallerstein R. Copy number variations in three children with sudden infant death. Clin Genet 2009, 76:63-68. 10.1111/j.1399-0004.2009.01161.x, 19659761.
97. Stankiewicz P, Lupski JR. Structural variation in the human genome and its role in disease. Annu Rev Med 2010, 61:437-455. 10.1146/annurev-med-100708-204735, 20059347.
98. Via M, Gignoux C, Burchard E. The 1000 Genomes Project: new opportunities for research and social challenges. Genome Med 2010, 2:3. 10.1186/gm124, 20193048.
99. Ackerman MJ, Splawski I, Makielski JC, Tester DJ, Will ML, Timothy KW, Keating MT, Jones G, Chadha M, Burrow CR, Stephens JC, Xu C, Judson R, Curran ME. Spectrum and prevalence of cardiac sodium channel variants among Black, White, Asian, and Hispanic individuals: implications for arrhythmogenic susceptibility and Brugada/long QT syndrome genetic testing. Heart Rhythm 2004, 1:600-607. 10.1016/j.hrthm.2004.07.013, 15851227.
100. Kapa S, Tester DJ, Salisbury BA, Harris-Kerr C, Pungliya MS, Alders M, Wilde AA, Ackerman MJ. Genetic testing for long-QT syndrome: distinguishing pathogenic mutations from benign variants. Circulation 2009, 120:1752-1760. 10.1161/CIRCULATIONAHA.109.863076, 19841300.
101. Millat G, Kugener B, Chevalier P, Chahine M, Huang H, Malicier D, Rodriguez-Lafrasse C, Rousson R. Contribution of long-QT syndrome genetic variants in sudden infant death syndrome. Pediatr Cardiol 2009, 30:502-509. 10.1007/s00246-009-9417-2, 19322600.
102. Otagiri T, Kijima K, Osawa M, Ishii K, Makita N, Matoba R, Umetsu K, Hayasaka K. Cardiac ion channel gene mutations in sudden infant death syndrome. Pediatr Res 2008, 64:482-487. 10.1203/PDR.0b013e3181841eca, 18596570.